UNITED STATES

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                   FORM 10-Q/A

[X] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities  Exchange
Act of 1934 For the quarter ended  September  30, 2000 or [ ] Transition  Report
Pursuant to Section 13 or 15(d) of the  Securities  Exchange Act of 1934 For the
transition period from to Commission File Number: 1-7234

                            GP STRATEGIES CORPORATION

(Exact Name of Registrant as Specified in its Charter)

         Delaware                                              13-1926739
(State or other jurisdiction of                             (I.R.S. Employer
incorporation or organization)                               Identification No.)

9 West 57th Street, New York, NY                                 10019
(Address of principal executive offices)                      (Zip code)

(212) 826-8500

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange act of 1934 during
the  preceding 12 months (or for such shorter  period) that the  registrant  was
required  to file  such  reports  and  (2)  has  been  subject  to  such  filing
requirements for the past 90 days.

                                    Yes X No

Number of shares  outstanding of each of issuer's  classes of common stock as of
November 9, 2000:

                  Common Stock                        12,114,837 shares
                  Class B Capital                        800,000 shares





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

EXPLANATORY NOTE

This Form 10-Q/A restates the Consolidated Condensed Statement of Operations for
the three and nine months ended September 30, 2000 as follows:

Gain on Trading  Securities is being  increased by $8,780,000 and the Income Tax
Benefit is being  decreased by $3,424,000 for the three and  nine-month  periods
ended  September 30, 2000.  The dollar value over the prior year gain on trading
securities  and income tax benefit in  Management's  Discussion and Analysis and
Financial  Condition and Results of Operations have been changed  accordingly to
reflect this adjustment.  In addition, the Form 10-Q/A restates the Consolidated
Balance Sheet as of September 30, 2000 as follows:  Accumulated Deficit is being
decreased by $5,356,000 and  Accumulated  Other  Comprehensive  Income (Loss) is
being decreased by $5,356,000. The Accumulated Other Comprehensive Income (Loss)
in the related note has been changed to reflect this adjustment.





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

                                TABLE OF CONTENTS

                                                                       Page No.
Part I.    Financial Information

                Consolidated Condensed Balance Sheets -
                  September 30, 2000 and December 31, 1999                 1

                Consolidated Condensed Statements of Operations -
                  Three Months and Nine Months Ended September 30,
                  2000 and 1999                                            3

                Consolidated Condensed Statements of Cash Flows -
                  Nine Months Ended September 30, 2000 and 1999            4

                Notes to Consolidated Condensed Financial

                  Statements                                               6

                Management's Discussion and Analysis of Financial

                  Condition and Results of Operations                     19

Part II.   Other Information                                              27

                  Signatures                                              28










                          PART I. FINANCIAL INFORMATION

                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

                      CONSOLIDATED CONDENSED BALANCE SHEETS

                                 (in thousands)

                                                 September  30,    December 31,
                                                          2000            1999
            ASSETS                                  (unaudited)           *
                                                  (As restated)

Current assets

Cash and cash equivalents                            $   3,890        $  4,068
Marketable securities                                   22,000
Accounts and other receivables                          47,826          55,385
Inventories                                              1,672           1,888
Costs and estimated earnings
 in excess of billings on uncompleted contracts         14,863          14,238
Prepaid expenses and other current assets                8,358           3,853
                                                    ----------      ----------

Total current assets                                    98,609          79,432
                                                     ---------          ------

Investments and advances                               124,125          16,557

Property, plant and equipment, net                       9,090          13,658

Intangible assets, net of accumulated
  amortization of $41,557 and $38,986                   60,884          79,818

Deferred tax asset                                        -              3,990

Other assets                                             4,396           3,663
                                                   -----------     -----------
                                                      $297,104        $197,118
                                                      ========        ========




* The  Consolidated  Condensed  Balance  Sheet as of December  31, 1999 has been
summarized  from the  Company's  audited  Consolidated  Balance Sheet as of that
date.


   See accompanying notes to the consolidated condensed financial statements.





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

                CONSOLIDATED CONDENSED BALANCE SHEETS (Continued)

                                 (in thousands)

                                                September  30,    December 31,
                                                         2000            1999
LIABILITIES AND STOCKHOLDERS' EQUITY             (unaudited)            *
                                                 (As restated)

Current liabilities:

Current maturities of long-term debt             $    1,383       $     3,668
Short-term borrowings                                37,607            40,278
Accounts payable and accrued expenses                36,788            25,634
Billings in excess of costs and estimated
 earnings on uncompleted contracts                   10,911             9,998
                                                  ---------       -----------

Total current liabilities                            86,689            79,578
                                                   --------         ---------

Long-term debt less current maturities               16,372            14,822
Deferred tax liability                               34,194             -
Other non-current liabilities                         3,659             2,736

Stockholders' equity

Common stock                                            122               115
Class B capital stock                                     8                 5
Additional paid in capital                          180,794           170,011
Accumulated deficit                                 (79,372)          (61,602)
Accumulated other comprehensive income (loss)        63,645              (817)
Note receivable from stockholder                     (4,094)           (2,817)
Treasury stock, at cost                              (4,913)           (4,913)
                                                  ---------        ----------
Total stockholders' equity                          156,190            99,982
                                                 ----------         ---------
                                                   $297,104          $197,118
                                                   ========          ========

* The  Consolidated  Condensed  Balance  Sheet as of December  31, 1999 has been
summarized  from the  Company's  audited  Consolidated  Balance sheet as of that
date.

   See accompanying notes to the consolidated condensed financial statements.





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

                 CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS

                                   (Unaudited)

                      (in thousands, except per share data)



                                                                 Three months               Nine months
                                                              ended September 30,             ended September 30,
                                                            ---------------------           ---------------------
                                                             2000             1999           2000            1999
                                                          -------           ------        -------           ------
                                                       (As restated)                     (As restated)

                                                                                              
Sales                                                    $ 50,786         $ 53,258       $148,914         $175,953
Cost of sales                                              45,965           46,022        134,782          153,946
                                                         --------         --------       --------        ---------
Gross margin                                                4,821            7,236         14,132           22,007

Selling, general & administrative expenses                (11,009)          (7,013)       (23,879)         (21,429)

Interest expense                                           (1,454)          (1,144)        (4,114)          (3,205)

Investment and other income (loss), net                    (2,373)          (1,332)        (2,092)            (590)

Gain on trading securities                                 20,780              693         21,248            1,257

Asset impairment charge                                      (771)                        (19,245)

Restructuring charges                                      (8,600)                         (8,600)          (6,312)
                                                       ----------    -------------      ---------        ---------

Income (loss) before income taxes                           1,394           (1,560)       (22,550)          (8,272)

Income tax (expense) benefit                                5,155             (262)         4,780           (1,119)
                                                        ---------       ----------      ---------        ---------

Net income (loss)                                        $  6,549         $ (1,822)      $(17,770)        $ (9,391)
                                                         ========         ========       ========         ========

Net income (loss) per share:

Basic and diluted                                       $     .52       $    (.16)      $  (1.44)        $   (.82)
                                                        =========       =========       ========         ========

Dividends per share                                        none             none            none             none
                                                         ========       ==========       ========        ========



   See accompanying notes to the consolidated condensed financial statements.





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

                 CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

                                   (Unaudited)
                                  (in thousands)



                                                                      Nine months
                                                                    ended September 30,
                                                                 2000              1999
                                                               -------            ------
                                                            (As restated)

Cash flows from operations:
                                                                        
Net loss                                                     $(17,770)        $  (9,391)
Adjustments to reconcile net loss to net cash
provided by (used for) operating activities:
  Depreciation and amortization                                 4,986             5,274
  Proceeds from sale of trading securities                        684             3,577
  Gain on trading securities                                  (21,248)           (1,257)
  Issuance of stock for profit incentive plan                   1,027             1,001
  Equity loss on investments                                    2,959             1,302
  Non-cash compensation expense                                 6,163
  Asset impairment charge                                      19,245
  Restructuring charge                                          8,600             6,312
  Deferred tax benefit                                         (5,535)
  Changes in other operating items                              2,050           (11,027)
                                                             --------          --------
  Net cash provided by (used for) operating activities          1,161            (4,209)
                                                             --------         ---------

Cash flows from investing activities:

Additions to property, plant & equipment                         (562)           (2,828)
Additions to intangible assets, net                              (454)             (744)
Proceeds from disposal of fixed assets                            507
(Increase) decrease of investments and other assets, net       (1,215)              527
                                                            ---------          --------
Net cash (used for) provided by investing activities           (1,724)            3,045
                                                            ---------         ---------







                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

           CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Continued)

                                   (Unaudited)
                                 (in thousands)



                                                                      Nine months
                                                                     ended September 30,

                                                                  2000              1999
                                                             ---------           -------
                                                             (As restated)

Cash flows from financing activities:

                                                                             
(Repayment of) proceeds from short-term borrowings              (2,671)            7,523
Proceeds from sale of Class B Stock                              1,200
Proceeds from subordinated convertible debentures                2,640
Repayment of long-term debt                                     (1,258)           (2,272)
Exercise of common stock options and warrants                      189               910
Repurchase of treasury stock                                    -                 (1,129)
                                                           -----------           -------
Net cash provided by financing activities                          100             5,032
                                                             ---------           -------
Effect of exchange rate changes on
Cash and cash equivalents                                          285               317
                                                             ---------          --------

Net decrease in cash and cash equivalents                         (178)           (1,905)
Cash and cash equivalents at the beginning of the periods        4,068             6,807
                                                              --------          --------
Cash and cash equivalents at the end of the periods           $  3,890          $  4,902
                                                              ========          ========


Cash paid during the periods for:

 Interest                                                     $  4,253          $  3,930
                                                              ========          ========
 Income taxes                                                 $    361          $    955
                                                              =========         =========







   See accompanying notes to the consolidated condensed financial statements.





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

              NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

                                   (Unaudited)

1.   Qualification relating to financial information

The  financial  information  included  herein is  unaudited.  In  addition,  the
financial  information does not include all disclosures required under generally
accepted accounting  principles because certain note information included in the
Company's Annual Report has been omitted; however, such information reflects all
adjustments  (consisting  solely of normal recurring  adjustments) which are, in
the opinion of management,  necessary to a fair statement of the results for the
interim  periods.  The results for the 2000 interim  period are not  necessarily
indicative of results to be expected for the entire year.

2.   Earnings per share

Income (loss) per share (EPS) for the periods ended  September 30, 2000 and 1999
are as follows (in thousands, except per share amounts):




                                           Three months                    Nine months
                                        ended September 30,             ended September 30,
                                            2000          1999            2000             1999
                                         (As restated)                (As restated)

Basic and Diluted EPS

                                                                           
Net income (loss)                   $   6,549           $ (1,822)      $(17,770)       $  (9,391)
Weighted average shares

Outstanding                            12,692             11,287         12,302           11,407
Basic and diluted net income
(loss) per share                    $     .52           $   (.16)      $  (1.44)        $   (.82)



         Basic earnings per share are based upon the weighted  average number of
common shares outstanding,  including Class B common shares,  during the period.
Class B common  stockholders have the same rights to share in profits and losses
and liquidation values as common  stockholders.  In 1999 and for the nine months
ended  September  30, 2000,  even though the Company still has stock options and
warrants  outstanding,  diluted  earnings per share is not  presented due to the
Company's  net  loss,  which  makes  the  effect  of  the  potentially  dilutive
securities  anti-dilutive.  For the quarter ended  September 30, 2000,  weighted
average shares outstanding assuming dilution is 12,747,000 shares.





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

        NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Continued)

                                   (Unaudited)

3.       Long-term debt

Long-term debt consists of the following (in thousands):

                                              September 30,         December 31,
                                                2000                    1999
                                              --------                ------
8% Swiss bonds due 2000*                   $                          $  2,175
Subordinated convertible debentures               2,640
Senior subordinated debentures                      762                    844
Term loan                                        13,500                 14,063
Other                                               853                  1,408
                                              ---------               --------
                                                 17,755                 18,490
Less current maturities                          (1,383)                (3,668)
                                              ---------               --------
                                                $16,372                $14,822
                                                =======                =======

*On June 28, 2000,  the Company  issued  443,097 shares of its Common Stock at a
value of $5.1625 per share, in exchange for the total principal and interest due
of the Company's 8% Swiss bonds.

On July 7, 2000, the Company,  in a private placement  transaction (the "Private
Placement") with two institutional  investors,  received  $2,640,000 in exchange
for 6%  Convertible  Exchangeable  Notes due June 30,  2003 (the  "Notes").  The
Notes,  at the  option  of the  holders,  may be  exchanged  for  19.99%  of the
outstanding  capital stock of Hydro Med,  Inc.  ("Hydro  Med"),  a newly formed,
wholly-owned  subsidiary,  on a fully diluted basis, as defined in the Notes, or
into shares of the  Company's  Common  Stock at a  conversion  rate of $7.50 per
share, subject to adjustment, as provided in the Notes. The holders of the Notes
can convert or exchange at any time prior to June 30, 2003. In  connection  with
the  Private  Placement,  the  Company  transferred  the assets of its Hydro Med
Sciences  division to Hydro Med, a wholly owned  subsidiary of the Company,  and
granted the holders of the Notes a security interest in approximately  19.99% of
the capital stock of Hydro Med to secure payment of the Notes.

Hydro Med develops,  manufactures,  markets and sells proprietary,  implantable,
controlled release drug delivery products, which release drugs directly into the
circulatory  system,  for human and veterinary  applications and is focusing its
efforts to obtain Food and Drug Administration  Approval for its prostate cancer
drug delivery system.





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

        NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Continued)

                                   (Unaudited)

4.       Comprehensive income (loss)

The following are the components of comprehensive income (loss) (in thousands):



                                                          Three months ended             Nine months ended
                                                             September 30,                September 30,
                                                          2000           1999            2000         1999
                                                    (As restated)                    (As restated)

                                                                                      
Net income (loss)                                    $   6,549         (1,822)       $(17,770)    $ (9,391)
                                                     ---------         ------        ---------    --------
Other comprehensive income
(loss) before tax:
Net unrealized gain (loss) on
 available-for-sale-securities                         103,901           (391)        104,500         (567)
Foreign currency translation adjustment                    670            122             795          317
                                                    ----------     ----------      ----------    ---------
Other comprehensive income (loss),
 before tax                                            104,571           (269)        105,295         (250)
Income tax benefit (expense) relating to
 items of other comprehensive income                   (40,789)           133         (40,833)         193
                                                     ---------      ---------       ---------   ----------
Comprehensive income (loss), net of tax               $ 70,331       $ (1,958)       $ 46,692     $ (9,448)
                                                      ========       ========        ========     ========


The components of accumulated other comprehensive income (loss) are as follows:

                                               September 30,     December 31,
                                                  2000               1999
                                                ---------          -------
                                             (As restated)

Net unrealized gain (loss) on
 available-for-sale-securities                 $104,445          $     (55)
Foreign currency translation adjustment              36               (759)
                                             ----------           --------
Accumulated other comprehensive income
(loss) before tax                               104,481               (814)
Accumulated income tax expense related to
items of other comprehensive income (loss)      (40,836)                (3)
                                              ---------          ---------
Accumulated other comprehensive
income (loss), net of tax                      $ 63,645           $   (817)
                                               ========           ========





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

        NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Continued)

                                   (Unaudited)

5.       Credit agreement

         The Company and General  Physics  Canada Ltd. (GP  Canada),  an Ontario
corporation  and a wholly-owned  subsidiary of General  Physics,  entered into a
credit agreement, dated as of June 15, 1998 (the Credit Agreement), with various
banks  providing  for a secured  credit  facility  of  $80,000,000  (the  Credit
Facility)  comprised of a revolving  credit facility of $65,000,000  expiring on
June 15, 2001 and a five-year term loan of $15,000,000.  The five year term loan
is payable in 20 quarterly  installments  of $187,500  commencing  on October 1,
1998 with a final payment of $11,250,000 due on June 15, 2003.

         Due to the Company's restructuring charges and operating losses in 1999
and the restructuring charges,  operating losses and asset impairment charges in
2000,  primarily  related to General  Physics' IT Group,  the Company was not in
compliance with respect to the financial covenants in the Credit Agreement as of
September  30, 1999,  December 31, 1999,  March 31, 2000 and June 30, 2000.  The
Company and its lenders entered into  agreements  dated as of April 12, 2000 and
July 31, 2000 providing for waivers of compliance with such covenants at each of
those four dates.

         Effective  as of August  29,  2000,  the  Company  and  certain  of its
wholly-owned   subsidiaries   entered  into  an  Amended  and  Restated  secured
$63,500,000  Revolving Credit and Term Agreement (the "Amended Agreement") which
amended in its entirety the Company's  Credit  Agreement  described  above.  The
Amended  Agreement  reduced  the  commitment  pursuant to the  revolving  credit
agreement to $50,000,000 (subject to borrowing base limitations specified in the
Amended  Agreement),  however the Amended  Agreement  did not change the payment
terms of the term loan which currently has an outstanding balance of $13,500,000
as well as the  expiration  date on both the credit  facility and the term loan.
The interest rates increased on both the revolving credit agreement and the term
loan to prime  plus  1.25%  (increased  from  .50%) and  Eurodollar  plus  2.75%
(increased from 2.00%). The Amended Agreement  provides for additional  security
consisting of certain real property,  personal  property and  substantially  all
marketable  securities  owned by the Company and its  subsidiaries  and contains
certain restrictive covenants, including the prohibition on future acquisitions,
and provides for mandatory prepayment upon the occurrence of certain events. The
Amended  Agreement  also  contains  revised  minimum  net  worth,  fixed  charge
coverage,  EBITDA and consolidated  liabilities to tangible net worth covenants.
Although there can be no assurance, the Company anticipates that it will satisfy
the revised  covenants  in the future.  At September  30, 2000,  the Company had
approximately $10,600,000 available to be borrowed under the Amended Agreement.





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

        NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Continued)

                                   (Unaudited)

6.       Business segments

         The operations of the Company  currently  consist of the following four
business  segments,  by which the Company is managed.  The  Company's  principal
operating  subsidiary is General Physics  Corporation  (GP). GP is a performance
improvement company that assists  productivity driven  organizations to maximize
workforce performance by integrating people,  processes and technology.  GP is a
total solutions  provider for strategic  training,  engineering,  consulting and
technical support services to Fortune 500 companies,  government,  utilities and
other  commercial  customers.  GP  operates  in  three  business  segments.  The
Manufacturing  Services  Group  provides  technology-based  training  to leading
companies in the automotive,  steel and food and beverage industries, as well as
to the  government  sector.  The Process & Energy  Group  provides  engineering,
consulting  and  technical   training  to  the  power,   chemical,   energy  and
pharmaceutical  industries as well as  government  facilities.  The  Information
Technology Group provides information training programs and solutions, including
Enterprise Solutions and comprehensive career training and transition programs.

         The  Optical  Plastics  Group,  which  is the  Company's  wholly  owned
subsidiary MXL Industries,  Inc. (MXL),  manufactures and distributes coated and
molded plastic products.

The management of the Company does not allocate the following  items by segment:
Investment and other income (loss), net, interest expense,  selling, general and
administrative  expenses,  depreciation  and  amortization  expense,  income tax
expense,  significant  non-cash items and long-lived assets. There are deminimis
inter-segment  sales. The reconciliation of gross margin to net income (loss) is
consistent with the  presentation on the  Consolidated  Condensed  Statements of
Operations.





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

        NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Continued)

                                   (Unaudited)

6.       Business segments (Continued)

The  following  tables  set forth  the  sales  and  gross  margin of each of the
Company's operating segments (in thousands):




                               Three months ended                  Nine months ended
                               September  30,                    September  30,
                               ------------------             -----------------
                                     2000          1999           2000          1999
                                  -------      --------        -------       -------

Sales

                                                                
Manufacturing Services           $ 21,185       $20,277       $ 55,994      $ 67,018
Process and Energy                 21,113        17,254         63,385        56,571
Information Technology              6,125        13,290         21,117        44,234
Optical Plastics                    2,363         2,432          8,278         7,637
Other                              -                  5            140           493
                               ----------   -----------    -----------   -----------
                                 $ 50,786      $ 53,258       $148,914      $175,953
                                 --------      --------       --------      --------

Gross margin

Manufacturing Services           $  3,067     $   3,717       $  7,564      $ 11,356
Process and Energy                  3,013         2,857          8,472         8,137
Information Technology             (1,666)          228         (3,671)          404
Optical Plastics                      587           622          2,188         2,023
Other                                (180)         (188)          (421)           87
                               ----------     ---------     ----------    ----------
                                $   4,821      $  7,236       $ 14,132      $ 22,007
                                ---------      --------       --------      --------






                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

        NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Continued)

                                   (Unaudited)

6.       Business segments (continued)

Information about the Company's net sales in different geographic regions, which
are  attributed to countries  based on location of customers,  is as follows (in
thousands):

                          Three months ended          Nine months ended
                              September  30,              September 30,
                    ------------------------    -----------------------
                        2000          1999           2000          1999
                     ---------     ---------      ---------     -------

United States       $ 44,787      $ 41,603       $127,887      $136,501
Canada                 2,131         5,889          8,158        21,134
United Kingdom         2,706         4,285          9,467        13,290
Latin America          1,162         1,481          3,402         5,028
                    --------    ----------      ---------    ----------
                    $ 50,786      $ 53,258       $148,914      $175,953
                    --------      --------       --------      --------


Information  about the  Company's  identifiable  assets in different  geographic
regions, is as follows (in thousands):


                                    September 30,              December 31,
                                        2000                        1999
                                   ---------            ----------------
United States                      $286,851                     $180,057
Canada                                4,317                        9,533
United Kingdom                        2,884                        5,087
Latin America                         3,052                        2,441
                                   --------                     --------
                                   $297,104                     $197,118
                                   --------                     --------






                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

        NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Continued)

                                   (Unaudited)

7.       Asset impairment charge and restructuring charge

         The operations of the  Information  Technology (IT) Group are primarily
comprised of the operations of Learning Technologies, which was purchased by the
Company in June 1998. As a result of the purchase of Learning Technologies,  the
Company  recorded  $23,216,000  of goodwill,  which was being  amortized over 30
years.

         During 1999, the Company adopted restructuring plans, primarily related
to its IT Business segment.  The Company took steps in order to change the focus
of the IT group from open enrollment  information technology training courses to
project oriented work for  corporations,  which was consistent with the focus of
General  Physics  Corporation's  (GP) current  business.  In connection with the
restructuring,  the Company closed,  downsized, or consolidated 7 offices in the
United  States,  10 offices in Canada and 5 offices in the United  Kingdom (UK),
and terminated approximately 156 employees.

         The Company  believed at that time that the strategic  initiatives  and
cost cutting  moves taken in 1999 and the first quarter of 2000 would enable the
IT Group to return to  profitability  in the last six  months of 2000.  However,
those plans were not  successful,  and the Company  determined  that it could no
longer bring the open enrollment IT business to profitability,  and additionally
there had been an impairment to intangible and other assets.

         In July 2000, as a result of the continued operating losses incurred by
its IT Group, as well as the  determination  that revenues would not increase to
profitable levels, the Company closed its open enrollment business in the UK and
Canada.

         As a result,  for the quarter and nine months ended September 30, 2000,
the Company has recorded asset  impairment  charges of $771,000 and $19,245,000,
respectively,  related to the IT Group. The charges are comprised of a write-off
of intangible  assets of $16,663,000  (of which  $16,056,000 was recorded during
the six months ended June 30, 2000),  as well as  write-offs of property,  plant
and  equipment and other assets  relating to the offices to be closed,  totaling
$2,582,000 (of which  $2,418,000  was recorded  during the six months ended June
30, 2000).

         The  Company  believes  that  the  remaining  unamortized  goodwill  of
approximately  $5,400,000,  which  relates  to the US and  Canadian  IT  project
business,  is recoverable from future operations.  However,  if the remaining IT
operations  do  not  achieve  profitable  operating  results,  there  can  be no
assurance that a further impairment charge will not be required.





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

        NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Continued)

                                   (Unaudited)

7.       Asset impairment charge and restructuring charge (Continued)

         In addition, in connection with the restructuring, the Company recorded
a  restructuring   charge  of  $8,600,000,   net  of  a  reversal  of  the  1999
restructuring charge of $768,000 during the quarter ended September 30, 2000.

The components of the 2000 restructuring charges are as follows (in thousands):




                                Severance     Lease and                  Other facility
                              and related     related        Contractual    related
                                 benefits     obligations    obligations     costs        Total
- -----------------------------------------------------------------------------------------------------
Restructuring
                                                                        
 charges during 2000              $ 1,825         $ 5,290        $ 2,043     $  210       $ 9,368
Utilization                           847             296                        39         1,182
- -----------------------------------------------------------------------------------------------------
Balance September 30, 2000       $    978         $ 4,994        $ 2,043     $  171       $ 8,186
- -----------------------------------------------------------------------------------------------------


         The Company  anticipates  recording an additional  charge in the fourth
quarter of 2000, related to the IT Group due to continuing exit costs associated
with the offices and operations closed.

         In  connection  with the  Company's  1999  restructuring,  the  Company
recorded a restructuring  charge of $7,374,000 in 1999.  During the period ended
September 30, 2000 and the year ended  December 31, 1999,  the Company  utilized
$2,043,000 and $2,754,000, respectively.

         The  components  of the 1999  restructuring  charges are as follows (in
thousands):



                                       Severance         Lease and        Other facility
                                      and related        related            related
                                      benefits           obligations         costs          Total
- ---------------------------------------------------------------------------------------------------
                                                                        
Balance December 31, 1999                 $   289            $ 4,206       $    125       $ 4,620
- ------------------------------------------------------------------------------------------------------
Utilization                                   184              1,806             53         2,043
Reversal of restructuring charges
during 2000                                                      768                          768
- ------------------------------------------------------------------------------------------------------
Balance September 30, 2000               $    105            $ 1,632       $     72       $ 1,809
- ------------------------------------------------------------------------------------------------------







                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

        NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Continued)

                                   (Unaudited)

7.       Asset impairment charge and restructuring charge (Continued)

         The remaining  amounts that have been accrued for severance and related
benefits will be expended by December 31, 2000. Lease  obligations are presented
at their present value are net of assumed sublets.  Other facility related costs
will be expended through 2001. Of the remaining  unexpended amounts at September
30, 2000 and December 31, 1999,  $6,336,000 and  $1,884,000,  respectively,  was
included in Accounts payable and accrued expenses and $3,659,000 and $2,736,000,
respectively,  was included in Other non-current liabilities in the Consolidated
Balance Sheet.

8.       Termination of merger agreement

         On February 11, 2000, the Company  terminated its previously  announced
merger  agreement  with VS&A  Communications  Partners  III, L.P.  ("VS&A"),  an
affiliate of Veronis,  Suhler &  Associates  Inc. To induce VS&A to agree to the
immediate  termination of the merger agreement and to give the Company a general
release,  on  February  11,  2000,  the  Company  issued  to  VS&A,  as  partial
reimbursement  of the  expenses  incurred  by it in  connection  with the merger
agreement,  83,333 shares of the Company's  Common Stock and an 18-month warrant
to purchase 83,333 shares of the Company's  Common Stock at a price of $6.00 per
share.  The  consideration  was  valued at  $686,000,  and was  included  in the
December 31, 1999 consolidated statement of operations.

9.       Class B Capital Stock

         On February 11, 2000,  an affiliate of Andersen,  Weinroth & Co.,  L.P.
("Andersen  Weinroth") purchased 200,000 shares of the Company's Class B Capital
Stock for $6.00 per share for a total cost of $1,200,000.  In addition, G. Chris
Andersen joined the Board of Directors of the Company. Mr. Andersen is a general
partner of Andersen Weinroth.

10.      Related party transactions

         During the first quarter of 2000,  the Company made loans to an officer
who is the  President and Chief  Executive  Officer as well as a director of the
Company totalling  approximately  $1,277,000 to purchase an aggregate of 150,000
shares of Class B Capital Stock. In addition,  at December 31, 1999, the Company
had  loans   receivable  from  such  officer  in  the  amount  of  approximately
$2,817,000.





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Continued)

                                   (Unaudited)

10.      Related party transactions (Continued)

         The  officer  primarily  utilized  the  proceeds  of the prior loans to
exercise  options to purchase an aggregate of 408,512  shares of Class B Capital
Stock.  Such loans bear interest at the prime rate of Fleet Bank and are secured
by the purchased  Class B Capital Stock and certain other assets.  All principal
on the loans and accrued  interest  ($430,000 at September  30, 2000) are due on
May 31, 2004. In prior years,  the Company made unsecured  loans to such officer
in the amount of  approximately  $480,000,  which unsecured loans primarily bear
interest at the prime rate of Fleet Bank.

11.      Investments

         Millennium  Cell Inc.  ("Millennium")  is a  development  stage company
which is  engaged in the  development  of a patented  and  proprietary  chemical
process that converts sodium  borohydride to hydrogen.  As of June 30, 2000, the
Company had a 27%  ownership  interest  (prior to the  completion of the Initial
Public Offering ("IPO") described below)  representing  approximately  6,000,000
shares including approximately 550,000 shares of common stock subject to options
given to the Company's employees to acquire Millennium shares from the Company's
holdings.  The Company  accounted for this investment under the equity method of
accounting.

         On August 14, 2000,  Millennium completed an IPO of 3,000,000 shares of
common stock at a price of $10 per share. Based upon the consummation of the IPO
which reduced the Company's  holdings in Millennium  from  approximately  27% to
approximately 22.2% and certain  organizational  changes including lack of Board
representation,  in  Millennium,  the  Company  believes  that it does  not have
significant  influence on the operating and financial policies of Millennium and
as such now believes that it is appropriate to account for this investment under
the cost method of accounting.

         The majority of the Company's  shares of common stock in Millennium are
subject to a lock-up provision until February 9, 2001, and accordingly cannot be
sold by the Company  before  that date,  unless the  provision  is waived by the
underwriter.  In addition,  the Company's  shares  (excluding the 550,000 shares
subject to options) have been pledged to its bank to secure its credit facility.





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

        NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Continued)

                                   (Unaudited)

11.      Investments (Continued)

         As the Company  intends to dispose of 1,000,000  shares within the near
term the underwriter has agreed to waive the lock-up provisions on these shares.
Accordingly,  the Company has classified these shares as trading securities.  At
September 30, 2000, these shares had a value of approximately $22,000,000.

         The  approximately  5,000,000  shares  remaining are not expected to be
sold  within the near term and, as such are  classified  as  available  for sale
securities.  At September  30, 2000,  these shares had a value of  approximately
$111,000,000.

         In  connection  with  the IPO  the  Company  recorded  an  increase  of
approximately $7,300,000 in its investment in Millennium which was credited, net
of taxes,  to additional  paid-in  capital in accordance  with Staff  Accounting
Bulletin 51.

         On  February  11,  2000,  the  Company  granted  options to purchase an
aggregate of approximately  550,000 of its shares of Millennium  common stock to
certain of its employees  pursuant to the GP Strategies  Corporation  Millennium
Cell, LLC Option Plan (the  "Millennium  Option Plan"),  which options vest over
either a one year or two year  period and expire on May 11,  2002.  The  Company
will receive approximately $500,000 upon exercise of all options pursuant to the
Millennium  Option Plan. As a result of the Millennium  Option Plan, the Company
recorded net  deferred  compensation  of  $5,039,000,  to be amortized  over the
remaining  vesting  period of the  options,  and a  liability  to  employees  of
$11,702,000  at  September  30,  2000.  These  amounts  are  included in Prepaid
expenses and other  current  assets and Accounts  payable and accrued  expenses,
respectively,  on the  Consolidated  Condensed  Balance  Sheet.  Pursuant to the
vesting  provisions  of the  Millennium  Option  Plan,  the  Company  recorded a
non-cash  compensation  expense of $4,563,000 and $6,163,000 for the quarter and
nine months ended September 30, 2000, which is included in Selling,  general and
administrative expenses in the Consolidated Condensed Statement of Operations.





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

        NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Continued)

                                   (Unaudited)

12.      Restatements

         The Company has restated its  Consolidated  Financial  Statements as of
September  30,  2000 and for three and nine  months  ended  September  30,  2000
because of  adjustments  that were  identified  related to the allocation of the
cost basis of Millennium Cell between available-for-sale  securities and trading
securities.

         The impact of the restatement on the Company's Consolidated  Statements
of  Operations  for the  three  and nine  months  ended  September  30,  2000 is
summarized as follows:




                                                         Three Months Ended                   Nine Months Ended
                                                         September 30, 2000                   September 30, 2000
                                                -----------------------------------------------------------------
                                                  As reported          Restated            As reported        Restated

                                                                                                  
Gain on trading securities                        $  12,000            $20,780             $12,468            $21,248
Income tax benefit                                    8,579              5,155               8,204              4,780
Net Income (Loss)                                     1,193              6,549             (23,126)           (17,770)

Basic and diluted income (loss) per share               .09                .52              (1.88)             (1.44)



         The impact of the  restatement  on the Company's  Consolidated  Balance
Sheet as of September 30, 2000 is summarized as follow:

                                                              As of
                                                         September 30, 2000
                                                    As reported         Restated

Accumulated Deficit                                  $ (84,728)       $ (79,372)
Accumulated Other Comprehensive Income                  69,001           63,645








                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

           MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

                            AND RESULTS OF OPERATIONS

                              RESULTS OF OPERATIONS

Overview

         The  Company  has  four  operating  business  segments.  Three  of  the
Company's  segments  are  managed  through  the  Company's  principal  operating
subsidiary, GP, and the fourth through its operating subsidiary, MXL Industries,
Inc. (MXL). In addition, the Company holds a number of investments in public and
privately held companies.

         GP is a  performance  improvement  company  that  assists  productivity
driven  organizations to maximize workforce  performance by integrating  people,
processes  and  technology.  GP  is a  total  solution  provider  for  strategic
training, engineering,  consulting and technical support services to Fortune 500
companies,  government, utilities and other commercial customers. GP consists of
three  segments:  the  Information  Technology  (IT)  Group,  the  Manufacturing
Services Group and the Process & Energy Group. The Optical Plastics Group, which
comprises MXL, manufactures molded and coated optical products,  such as shields
and facemasks and non-optical plastic products.

         The Company had income  before  income taxes of  $1,394,000  and a loss
before  income  taxes of  $22,550,000  for the  quarter  and nine  months  ended
September 30, 2000, respectively,  compared to a net loss before income taxes of
$1,560,000 and  $8,272,000  for the quarter and nine months ended  September 30,
1999,  respectively.  The operating loss for the nine months ended September 30,
2000, was primarily due to an Asset impairment  charge of $19,245,000,  of which
$18,474,000  was taken in the second quarter and $771,000 was taken in the third
quarter of 2000 and a $8,600,000 Restructuring charge taken in the third quarter
of 2000.  These  charges  were the  result of the  continuing  operating  losses
incurred  by the IT Group,  due to the trend of reduced  revenue on a  quarterly
basis,  which began in 1999 and continued  through 2000, and as such the IT open
enrollment businesses in UK and Canada were closed in the third quarter of 2000.
The quarter ended September 30, 2000,  included a $20,780,000 gain, which offset
the other charges to result in an income before income taxes of $1,394,000.

         In addition,  for the quarter and nine months ended September 30, 2000,
the Company also  recorded a $4,563,000  and  $6,163,000  non-cash  compensation
expense related to a compensation plan offered to certain of its employees which
is included in selling,  general and administrative expenses (See Note 11 to the
Consolidated Condensed Financial Statements).



         For the third quarter of 2000 the Company had a gain of $20,780,000 for
the quarter and  $21,248,000  for the nine months  ended  September  30, 2000 on
trading  securities  primarily  relating to 1,000,000  shares of Millennium Cell
stock, which are classified as trading securities.  In addition, the Company had
equity losses of $2,847,000  for the quarter and  $2,959,000 for the nine months
ended  September 30, 2000 which were primarily the result of the Company writing
down its  investment in the Five Star Group by  approximately  $2,400,000 in the
third quarter of 2000 due to an "other than  temporary"  decline in the value of
this investment.

         The Company had a loss before income taxes of $1,560,000 and $8,272,000
for the quarter and nine months ended  September 30, 1999. The loss for the nine
months ended  September  30, 1999 was primarily  due to a  Restructuring  charge
recorded in the quarter  ended June 30, 1999  totaling  $6,312,000,  principally
related to the Company's IT business  segment as well as other costs incurred by
the IT group in exiting certain activities.  These charges were included in Cost
of sales and Selling,  general and  administrative  expenses,  and included such
items as: payroll and related benefits,  facility-related  costs,  write-offs of
other assets and losses on contracts.

         The Manufacturing Services Group also had reduced operating profits due
to reduced sales and gross margin  percentage in the nine months ended September
30, 2000,  compared to the nine months ended September 30, 1999. For the quarter
ended September 30, 2000, the  Manufacturing  Group had reduced operating profit
due to reduced  gross  margin  percentages.  The  Process  and Energy  Group had
increased  operating  profit for the nine months ended  September  30, 2000,  as
compared to the prior  year,  due to  increased  sales.  For the  quarter  ended
September 30, 2000, the Process and Energy Group has slightly improved operating
results  due  to  increased  sales.  In  addition,  the  Process  &  Energy  and
Manufacturing Services Groups had increased investments in internal training and
business  development  during  the first  nine  months of 2000.  The  Company is
focusing  its  business  development  activities  in 2000  on a  major  branding
campaign,  to  increase  the name  recognition  of GP,  as well as plant  launch
services,  e-Learning and the area of learning resource management.  The Company
believes that these investments in business  development are an integral part of
its effort to increase its revenues and gross margin percentage.

Asset impairment charge and restructuring charge

         The  operations  of  the  IT  Group  are  primarily  comprised  of  the
operations of Learning Technologies,  which was purchased by the Company in June
1998. As a result of the purchase of Learning Technologies, the Company recorded
$23,216,000 of goodwill, which is being amortized over 30 years.




         During 1999, the Company adopted restructuring plans, primarily related
to its IT Business segment.  The Company took steps in order to change the focus
of the IT Group from open enrollment  information technology training courses to
project oriented work for  corporations,  which was consistent with the focus of
GP's current business. In connection with the restructuring, the Company closed,
downsized,  or consolidated 7 offices in the United States, 10 offices in Canada
and 5 offices in the United  Kingdom  (UK),  and  terminated  approximately  156
employees.

         The Company  believed at that time that the strategic  initiatives  and
cost cutting  moves taken in 1999 and the first quarter of 2000 would enable the
IT Group to return to  profitability  in the last six  months of 2000.  However,
those plans were not  successful,  and the Company  determined  that it could no
longer bring the open enrollment IT business to profitability,  and additionally
that there had been an impairment to intangible and other assets.

         In July 2000, as a result of the continued operating losses incurred by
its IT Group, as well as the  determination  that revenues would not increase to
profitable levels, the Company closed its open enrollment business in the UK and
Canada.  In the third  quarter of 2000,  the open  enrollment  IT  business  was
closed.  The Company recorded a restructuring  charge of $8,600,000 in the third
quarter of 2000.

         As a result,  for the quarter and nine months ended September 30, 2000,
the Company has recorded an asset impairment  charge of $771,000 and $19,245,000
related to the IT Group. The charge includes a write-off of intangible assets of
$16,663,000 (of which  $16,056,000 was recorded during the six months ended June
30,  2000),  as well as  write-offs  of property,  plant and equipment and other
assets  relating  to the  offices  to be closed  totaling  $2,582,000  (of which
$2,418,000 was recorded during the six months ended June 30, 2000).

         The  Company  believes  that  the  remaining  unamortized  goodwill  of
approximately  $5,400,000,  which  relates  to the US and  Canadian  IT  project
business,  is recoverable from future operations.  However,  if the remaining IT
operations  do  not  achieve  profitable  operating  results,  there  can  be no
assurance that a further impairment charge will not be required.

         The Company  anticipates  recording an additional  charge in the fourth
quarter of 2000, due to continuing  exit costs  associated  with the offices and
operations closed related to the IT Group.



Sales

                                Three months ended          Nine months ended
                                  September 30,               September 30,
                              2000          1999           2000          1999

Manufacturing Services    $ 21,185       $20,277       $ 55,994      $ 67,018
Process and Energy          21,113        17,254         63,385        56,571
Information Technology       6,125        13,290         21,117        44,234
Optical Plastics             2,363         2,432          8,278         7,637
Other                       -                  5            140           493
                          --------   -----------    -----------   -----------
                          $ 50,786      $ 53,258       $148,914      $175,953
                          --------      --------       --------      --------

         For the quarter and nine months ended September 30, 2000,  consolidated
sales  decreased  by  $2,472,000  and  decreased by  $27,039,000,  respectively,
compared  to the  corresponding  periods of 1999.  The  reduced  sales  occurred
primarily within the IT Group due to the continuing  erosion of the Canadian and
UK IT training business.  The reduced sales of the Manufacturing  Services Group
for the nine  months  ended  September  30,  2000,  was the  result  of  revenue
generated  for several  large jobs in 1999 that were not  replaced  with jobs of
similar  dollar value in the first quarter of 2000.  The increased  sales within
the  Manufacturing  Services  Group from the third quarter of 1999 was primarily
the result of growth within the  Company's  automotive  sector.  The Process and
Energy  Group has  experienced  increased  sales for both the  quarter  and nine
months ended September 30, 2000.



Gross margin


                                       Three months ended                         Nine months ended
                                         September 30,                              September 30,
                                 2000       %        1999     %            2000       %        1999       %

                                                                                  
Manufacturing Services        $ 3,067       14.5   $ 3,717    18.3      $ 7,564      13.5     $11,356     16.9
Process and Energy              3,013       14.3     2,857    16.6        8,472      13.4       8,137     14.4
Information Technology         (1,666)                 228    17.2       (3,671)                  404       .9
Optical Plastics                  587       24.8       622    25.6        2,188      26.4       2,023     26.5
Other                            (180)                (188)                (421)                   87     17.6
                              -------             --------              -------             ---------
                              $ 4,821              $ 7,236     8.7      $14,132               $22,007
                              -------              -------              -------               -------


         The reduction in gross margin of  $7,875,000  for the nine months ended
September  30, 2000  occurred  within all segments of GP, as a result of reduced
sales and gross  margin  percentage.  The gross  margin  for the  quarter  ended
September 30, 2000 was $2,415,000  lower than the gross margin  achieved for the
quarter ended  September 30, 1999. The negative gross margin  incurred by the IT
Group in 2000  was the  result  of the  continued  decrease  in  sales,  and the
resulting  inability of the segment to cover its  infrastructure  and  operating
costs and closing  costs.  The reduced gross margin  percentage in the Process &
Energy  Group for the nine months ended  September  30, 2000 was  primarily  the
result of a change in the mix of services  provided,  including  reduced product
sales,  which  historically  generate  higher  gross  margin  percentages.   The
Manufacturing  Services  Group has a reduced  gross  margin  percentage  in 2000
compared to the third quarter and nine months of 1999,  due to the lack of plant
launch and other large projects,  which have historically generated higher gross
margins.




Selling, general and administrative expenses

         For the quarter and nine months  ended  September  30,  2000,  selling,
general and  administrative  (SG&A)  expenses were  $11,009,000  and $23,879,000
compared to $7,013,000 and  $21,429,000  incurred in the quarter and nine months
ended  September 30, 1999. The increased SG&A in 2000 is primarily  attributable
to the $4,563,000 and $6,163,000 of non-cash  compensation  expense related to a
compensation  plan offered to certain of its  employees  recorded in the quarter
and nine months ended September 30, 2000,  which was partially offset by reduced
costs  resulting  from the  restructuring  plans  which  occurred  in  1999.  In
addition, the Company continued to reduce SG&A at the corporate level.

Interest expense

         For the quarter and nine months  ended  September  30,  2000,  interest
expense was $1,454,000 and $4,114,000  compared to $1,114,000 and $3,205,000 for
the quarter and nine months ended  September 30, 1999.  The  increased  interest
expense in 2000 was primarily  attributable  to increased  interest rates in the
current period.

Investment and other income, net

         Investment and other income  (loss),  net were net losses of $2,373,000
and  $2,092,000  for the  quarter  and nine  months  ended  September  30,  2000
primarily from  $2,847,000  and  $2,959,000 of equity  losses.  Of these amounts
$2,400,000 is attributable to the write-down of the Company's  investment in the
Five Star Group due to an "other  than  temporary"  decline in the value of this
investment.  These amounts were partially  offset by other income.  For 1999 the
Company recognized a $1,000,000 loss of its investment in GSE Systems,  Inc. and
had other  losses of  $1,332,000  and  $590,000  for the quarter and nine months
ended September 30, 1999.

Income tax expense

         In the quarter and nine months ended  September  30, 2000,  the Company
recorded an income tax benefit of $5,155,000 and $4,780,000, respectively, which
represents  a federal  income tax  benefit  offset by state,  local and  foreign
income  taxes.  Due to the  increase  in value of the  Company's  investment  in
Millennium,  the Company now  anticipates it has the ability to utilize  current
net operating loss  carryforwards.  As such the Company now anticipates  that it
has the ability to utilize approximately  $11,000,000 of net deferred tax assets
consisting primarily of domestic net operating loss carryforwards  against which
a valuation  allowance was  previously  provided.  This deferred tax benefit was
offset by an increase in the  valuation  allowance of  approximately  $6,000,000
related  to  Canadian  net  operating  losses  which are not  anticipated  to be
utilized  and have  therefore  been  reserved  against.  In the quarter and nine
months ended  September  30, 1999,  the Company  recorded  income tax expense of
$262,000 and $1,119,000,  respectively,  which represents primarily state, local
and foreign tax expense.

Liquidity and capital resources

         At  September  30,  2000,  the  Company  had cash and cash  equivalents
totaling  $3,890,000.  The Company  has  sufficient  cash and cash  equivalents,
marketable  current and long-term  investments and borrowing  availability under
existing  and  potential  lines  of  credit  as well as the  ability  to  obtain
additional  funds from its operating  subsidiaries  in order to fund its working
capital requirements.



    The  decrease in cash and cash  equivalents  of $178,000 for the nine months
ended September 30, 2000 resulted from cash provided in financing  activities of
$100,000 and by cash provided by operations of  $1,161,000,  offset by cash used
in investing  activities of  $1,724,000.  Cash provided by financing  activities
consisted  primarily of proceeds  from the sale of  convertible  debentures  and
Class B Stock  partially  offset by  repayments  of  short-term  borrowings  and
long-term debt.

Due to the Company's  restructuring charges and operating losses in 1999 and the
operating  losses  and  asset  impairment  charge  in the  nine  months  of 2000
primarily  related  to  General  Physics'  IT  Group,  the  Company  was  not in
compliance with respect to the financial covenants in its credit agreement as of
September  30, 1999,  December 31, 1999,  March 31, 2000 and June 30, 2000.  The
Company and its lenders entered into  agreements  dated as of April 12, 2000 and
July 31, 2000,  providing for waivers of compliance  with such covenants at each
of those four dates. Effective as of August 29, 2000, the Company and certain of
its wholly  owned  subsidiaries  entered  into an Amended and  Restated  secured
$63,500,000  Revolving Credit and Term Agreement (the "Amended Agreement") which
amended in its entirety  the  Company's  former  credit  agreement.  The Amended
Agreement  reduced  the  commitment   pursuant  to  the  revolving  facility  to
$50,000,000  (subject to  borrowing  base  limitations  specified in the Amended
Agreement),  however the Amended  Agreement  did not change the payment terms of
the term loan which currently has an outstanding  balance of $13,500,000 as well
as the  expiration  date on both the  credit  facility  and the term  loan.  The
interest rates increased on both the revolving credit facility and the term loan
to prime plus 1.25%  (increased from .50%) and Eurodollar plus 2.75%  (increased
from 2.00%). The Amended Agreement provides for additional  security  consisting
of certain real property,  personal  property and all  substantially  marketable
securities  owned by the Company and its  subsidiaries and also contains certain
restrictive  covenants,  including the prohibition on future  acquisitions,  and
provides for mandatory  prepayment  upon the occurrence of certain  events.  The
Amended  Agreement  contains  revised minimum net worth,  fixed charge coverage,
EBITDA and consolidated  liabilities to tangible net worth  covenants.  Although
there can be no  assurance,  the Company  anticipates  that it will  satisfy the
revised  covenants  in the  future.  At  September  30,  2000,  the  Company had
approximately $10,600,000 available to be borrowed under the Amended Agreement.

         The Company  believes that cash generated from operations and borrowing
availability  under its  credit  agreement  and  marketable  securities  will be
sufficient to fund the working capital needs of the Company.

Recent accounting pronouncements

         In June  1998,  the  FASB  issued  Statement  of  Financial  Accounting
Standard No. 133 (SFAS 133),  "Accounting for Derivative Instruments and Hedging
Activities." This Statement  establishes  accounting and reporting standards for
derivatives  as  either  assets  or  liabilities.  It  requires  that an  entity
recognizes  all  derivatives as either assets or liabilities in the statement of
financial  position and measures those instruments at fair value. This Statement
as amended by SFAS 137 and 138 is  effective  for all fiscal  quarters of fiscal
years  beginning  after June 15,  2000.  The Company  will adopt SFAS 133,  when
effective,  which is currently anticipated to be by January 1, 2001. The Company
is  still  evaluating  its  position  with  respect  to the  use  of  derivative
instruments.



         In December 1999,  the SEC issued Staff  Accounting  Bulleting  No.101,
"Revenue  Recognition in Financial  Statements" ("SAB No. 101") which summarizes
certain of the SEC  staff's  views in  applying  generally  accepted  accounting
principles to revenue recognition in financial statements.  SAB No. 101, amended
by SAB  101A  issued  on March  24,  2000,  requires  registrants  to adopt  the
accounting guidance contained therein by no later than the second fiscal quarter
of the fiscal year beginning  after December 15, 1999. On June 26, 2000, the SEC
issued SAB No. 101B which postponed the  implementation of SAB No. 101 until the
fourth quarter of 2000. The Company does not believe that the  implementation of
SAB No. 101 will have a significant effect on its results of operations.

Adoption of a Common European Currency

         On January 1, 1999, eleven European countries adopted the Euro as their
common currency. From that date until January 1, 2002, debtors and creditors may
choose to pay or to be paid in Euros or in the former  national  currencies.  On
and after January 1, 2002, the former national currencies will cease to be legal
tender.

         The Company is currently  reviewing its information  technology systems
and  upgrading  them as  necessary  to ensure  that they will be able to convert
among the former national currencies and the Euro, and process  transactions and
balances in Euros, as required.  The Company has sought and received  assurances
from the  financial  institutions  with  which it does  business  that  they are
capable  of  receiving  deposits  and making  payments  both in Euros and in the
former  national  currencies.  The  Company  does not expect that  adapting  its
information  technology  systems to the Euro will have a material  impact on its
financial  condition  or results of  operations.  The Company is also  reviewing
contracts with customers and vendors calling for payments in currencies that are
to be replaced by the Euro, and intends to complete in a timely way any required
changes to those contracts.

         Adoption of the Euro is likely to have  competitive  effects in Europe,
as prices that had been stated in different national  currencies become directly
comparable to one another. In addition, the adoption of a common monetary policy
throughout the countries  adopting the Euro can be expected to have an effect on
the economy of the region.  These  competitive  and economic  effects  cannot be
predicted with certainty,  and there can be no assurance that they will not have
a material effect on the Company's business in Europe.





Forward-looking statements

         The forward-looking  statements contained herein reflect GP Strategies'
management's   current  views  with  respect  to  future  events  and  financial
performance.  These forward-looking  statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from those in
the forward-looking  statements,  all of which are difficult to predict and many
of which are beyond the control of GP Strategies,  including, but not limited to
those risks and  uncertainties  detailed in GP Strategies'  periodic reports and
registration statements filed with the Securities and Exchange Commission.





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

                           PART II. OTHER INFORMATION

Item 6.           EXHIBITS AND REPORTS ON FORM 8-K

                  a.       Exhibits

10.  Amended  and  Restated   Credit   Agreement  by  and  among  GP  Strategies
Corporation,  General Physics Canada,  Ltd., The Lenders Party hereto, and Fleet
Bank, National  Association,  as Agent, as Issuing Bank and as Arranger dated as
of June 15, 1998, as amended and restated as of August 29, 2000.

                  b.       Reports

                           None





                   GP STRATEGIES CORPORATION AND SUBSIDIARIES

                               September 30, 2000

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  in its  behalf by the
undersigned thereunto duly authorized.

                            GP STRATEGIES CORPORATION


DATE: March 27, 2001                          Jerome I. Feldman
                                              President &
                                              Chief Executive Officer

DATE: March 27, 2001                          Scott N. Greenberg
                                              Executive Vice President &
                                              Chief Financial Officer